Fetal hemoglobin in sickle cell anemia: Relationship to erythrocyte adhesion markers and adhesion

Blood

Volumn 97, Issue 9, 2001, Pages 2568-2573

  Yamaja Setty, B N ^a,b,c   Kulkarni, Surekha ^a,b,c   Dampier, Carlton D ^a,b,c   Stuart, Marie J ^a,b,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^c Marian Anderson Comprehensive Sickle Cell Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD36 ANTIGEN; CD71 ANTIGEN; HEMOGLOBIN F;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ERYTHROCYTE; ERYTHROCYTE ADHESIVENESS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFANT; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

EID: 0035353182     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.9.2568     Document Type: Article

References (39)

1. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337:762-769.
2. Hebbel RP, Boogaerts MA, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle cell anemia: a possible determinant of disease severity. N Engl J Med. 1980;302:992-995.
3. Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest. 1997;99:2561-2564.
4. Harlan JM. Introduction: anti-adhesion therapy in sickle cell disease. Blood. 2000;95:365-367.
5. Swerlick RA, Eckman JR, Kumar A, Jeitler M, Wick TM. α 4 β 1-integrin expression on sickle erythrocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood. 1993;82:1891-1899.
6. Joneckis CC, Ackley RL, Orringer EP, Wayner EA, Parise LV. Integrin α 4 β 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood. 1993;82:3548-3555.
7. Gee BE, Platt OS. Sickle reticulocytes adhere to VCAM-1. Blood. 1995;85:268-274.
8. Sugihara K, Sugihara T, Mohandas N, Hebbel RP. Thrombospondin mediated adherence of CD36+ sickle reticulocytes to endothelial cells. Blood. 1992;80:2634-2642.
9. Browne PV, Hebbel RP. CD36-positive stress reticulocytes in sickle cell anemia. J Lab Clin Med. 1996;127:340-347.
10. Thevenin BJM, Crandall I, Ballas SK, Sherman IW, Shohet SB. Band 3 peptides block the adherence of sickle cells to endothelial cells in vitro. Blood. 1997;90:4172-4179.
11. Hillery CA, Du MC, Montgomery RR, Scott JP. Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell ligand that binds thrombospondin and laminin. Blood. 1996;87:4879-4886.
12. Kuypers FA, Lewis RA, Hua M, et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood. 1996;87:1179-1187.
13. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood. 1996;88:1873-1880.
14. Closse C, Dachary-Pregent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Hematol. 1999;107:300-302.
15. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood. 1999;95:1293-1300.
16. Kumar A, Eckman JR, Wick TM. Inhibition of plasma-mediated adherence of sickle erythrocytes to microvascular endothelium by conformationally constrained RGD-containing peptides. Am J Hematol. 1996;53:92-98.
17. Kaul DK, Tsai HM, Liu D, Nakada MT, Nagel RL, Coller BS. Monoclonal antibodies to aVb3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. Blood. 2000;95:368-374.
18. Setty BNY, Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red cell adherence to endothelium: potential role in sickle cell disease. Blood. 1996;88:2311-2320.
19. Brittain HA, Eckman JR, Swerlick RA, Howard RJ, Wick TM. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion. Blood. 1993;81:2137-2143.
20. Gupta K, Gupta P, SoloveyA, Hebbel RP. Mechanism of interaction of thrombospondin with human endothelium and inhibition of sickle erythrocyte adhesion to human endothelial cells by heparin. Biochim Biophys Acta. 1999;1453:63-73.
21. Barabino GA, Liu XD, Ewenstein BM, Kaul DK. Anionic polysaccharides inhibit adhesion of sickle erythrocytes to the vascular endothelium and result in improved hemodynamic behavior. Blood. 1999;93:1422-1429.
22. Wick TM, Moake JL, Udden MM, Eskin SG, Sears DA, McIntire LV. Unusually large vWF multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest. 1987;80:905-910.
23. Lee SP, Cunningham ML, Hines PC, Joneckis CC, Orringer EP, Parise L. Sickle cell adhesion to laminin: potential role for the α5 chain. Blood. 1998;92:2951-2958.
24. Platt O, Thorington MS, Brambilla DJ, et al. Pain in sickle cell disease: rates and risks factors. N Engl J Med. 1991;325:11-16.
25. Orringer EP, Blythe DSB, Johnson AE, Phillips G, Dover GJ, Parker JC. Effects of hydroxyurea on HbF and water content in the red blood cells of dogs and patients with sickle cell anemia. Blood. 1991;78:212-216.
26. Ballas SK, Dover GJ, Charache S. Effect of hydroxyurea on the rheological properties of sickle erythrocytes. Am J Hematol. 1989;32:104-111.
27. Adragna NC, Fonseca P, Lauf PK. Hydroxyurea affects cell morphology, cation transport and red cell adhesion to cultured vascular endothelial cells. Blood. 1994;83:553-560.
28. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332:1317-1322.
29. Bridges KR, Barabino GD, Brugnara C, et al. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy. Blood. 1996;88:4701-4710.
30. Styles LA, Lubin B, Vichinsky E, et al. Decrease of VLA4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood. 1997;89:2554-2559.
31. Thorpe SJ, Thein SL, Sampietro M, Craig JE, Mahon B, Huehns ER. Immunochemical estimation of haemoglobin types in red blood cells by FACS analysis. Br J Haematol. 1994;87:125-132.
32. Campbell TA, Ware RE, Mason M. Detection of hemoglobin variants in erythrocytes by flow cytometry. Cytometry. 1999;35:242-248.
33. Setty BNY, Dampier CD, Stuart MJ. Arachidonic acid metabolites are involved in mediating red blood cell adherence to endothelium. J Lab Clin Med. 1995;125:608-617.
34. Del Vecchio PJ, Sharuk GS, MacElroy KS. Isolation and culture of cells from human retinal microvessels. Invest Opthalmol Vis Sci. 1984;25S:247.
35. Glasser BM, D'Amore PA, Michels RG, Patz A. Demonstration of vasoproliferative activity from mammalian retina. J Cell Biol. 1980;84:298-304.
36. Nagel RL, Bookchin RM, Johnson J, et al. Structural bases of the inhibitory effects of HbF and HbA2 on the polymerization of hemoglobin S. Proc Natl Acad Sci U S A. 1979;76:670-672.
37. Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW. Hematologic response of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med. 1990;322:1037-1045.
38. Steinberg MH, Lu Z, Barton FB, Terrin ML, Charache S, Dover GJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Blood. 1997;89:1078-1088.
39. Setty BNY, Kulkarni K, Rao AK, Stuart MJ. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood. 2000;96:1119-1124.